Condensed Consolidated Statements of Stockholders’ Deficit(Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2018	$ 14	$ 201,697	$ 82,637,749	$ (83,479,931)	$ (640,471)
Balance (in Shares) at Dec. 31, 2018	13,602	201,697,396
Stock-based compensation expense			122,950		122,950
Sale of common stock		$ 2,500	147,500		150,000
Sale of common stock (in Shares)		2,500,000
Net loss				(586,155)	(586,155)
Balance at Mar. 31, 2019	$ 14	$ 204,197	82,908,199	(84,066,086)	(953,676)
Balance (in Shares) at Mar. 31, 2019	13,602	204,197,396
Balance at Dec. 31, 2018	$ 14	$ 201,697	82,637,749	(83,479,931)	(640,471)
Balance (in Shares) at Dec. 31, 2018	13,602	201,697,396
Balance at Jun. 30, 2019	$ 14	$ 204,197	83,294,517	(84,852,906)	(1,354,178)
Balance (in Shares) at Jun. 30, 2019	13,602	204,197,396
Balance at Dec. 31, 2018	$ 14	$ 201,697	82,637,749	(83,479,931)	(640,471)
Balance (in Shares) at Dec. 31, 2018	13,602	201,697,396
Net loss					(4,007,317)
Balance at Sep. 30, 2019	$ 14	$ 204,197	84,722,612	(87,487,249)	(2,560,426)
Balance (in Shares) at Sep. 30, 2019	13,602	204,197,396
Balance at Mar. 31, 2019	$ 14	$ 204,197	82,908,199	(84,066,086)	(953,676)
Balance (in Shares) at Mar. 31, 2019	13,602	204,197,396
Stock-based compensation expense			386,318		386,318
Net loss				(786,820)	(786,820)
Balance at Jun. 30, 2019	$ 14	$ 204,197	83,294,517	(84,852,906)	(1,354,178)
Balance (in Shares) at Jun. 30, 2019	13,602	204,197,396
Stock-based compensation expense			1,428,095		1,428,095
Net loss				(2,634,343)	(2,634,343)
Balance at Sep. 30, 2019	$ 14	$ 204,197	84,722,612	(87,487,249)	(2,560,426)
Balance (in Shares) at Sep. 30, 2019	13,602	204,197,396
Balance at Dec. 31, 2019	$ 14	$ 206,569	85,907,523	(89,036,271)	(2,922,165)
Balance (in Shares) at Dec. 31, 2019	13,602	206,569,062
Stock-based compensation			439,956		439,956
Common stock issued on exercise of stock option and warrant		$ 25	1,725		1,750
Common stock issued on exercise of stock option and warrant (in Shares)		25,000
Sale of common stock		$ 3,710	1,109,290		1,113,000
Sale of common stock (in Shares)		3,710,000
Net loss				(1,265,091)	(1,265,091)
Balance at Mar. 31, 2020	$ 14	$ 210,304	87,458,494	(90,301,362)	(2,632,550)
Balance (in Shares) at Mar. 31, 2020	13,602	210,304,062
Balance at Dec. 31, 2019	$ 14	$ 206,569	85,907,523	(89,036,271)	(2,922,165)
Balance (in Shares) at Dec. 31, 2019	13,602	206,569,062
Net loss					(4,143,055)
Balance at Sep. 30, 2020	$ 14	$ 207,143	87,672,578	(93,179,326)	(5,299,591)
Balance (in Shares) at Sep. 30, 2020	13,602	207,143,146
Balance at Mar. 31, 2020	$ 14	$ 210,304	87,458,494	(90,301,362)	(2,632,550)
Balance (in Shares) at Mar. 31, 2020	13,602	210,304,062
Stock-based compensation			344,430		344,430
RSA-based non-cash compensation		$ 19	6,508		6,527
RSA-based non-cash compensation (in Shares)		18,750
Common stock issued on exercise of stock option and warrant		$ 1,050	72,450		73,500
Common stock issued on exercise of stock option and warrant (in Shares)		1,050,000
Sale of common stock		$ 1,770	529,330		531,100
Sale of common stock (in Shares)		1,770,334
Cancellation of common stock		$ (1,000)	1,000
Cancellation of common stock (in Shares)		(1,000,000)
Net loss				(1,374,709)	(1,374,709)
Balance at Jun. 30, 2020	$ 14	$ 212,143	88,412,212	(91,676,071)	(3,051,702)
Balance (in Shares) at Jun. 30, 2020	13,602	212,143,146
Stock-based compensation			344,033		344,033
RSA-based non-cash compensation			3,299		3,299
Recognize beneficial conversion feature			708,034		708,034
Accrual of payment in anticipation of settlement			(1,500,000)		(1,500,000)
Purchase and cancellation of common stock		$ (5,000)	(295,000)		(300,000)
Purchase and cancellation of common stock (in Shares)		(5,000,000)
Net loss				(1,503,255)	(1,503,255)
Balance at Sep. 30, 2020	$ 14	$ 207,143	$ 87,672,578	$ (93,179,326)	$ (5,299,591)
Balance (in Shares) at Sep. 30, 2020	13,602	207,143,146